Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
- 22 January 2010
- Vol. 28 (15) , 2705-2715
- https://doi.org/10.1016/j.vaccine.2010.01.022
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Targeted Mutagenesis as a Rational Approach to Dengue Virus Vaccine DevelopmentPublished by Springer Nature ,2009
- Molecular mechanisms of antibody-mediated neutralisation of flavivirus infectionExpert Reviews in Molecular Medicine, 2008
- Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope ProteinJournal of Virology, 2006
- Dengue and Dengue VaccinesThe Journal of Infectious Diseases, 2005
- Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic feverNature Medicine, 2003
- Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease SeverityThe Journal of Infectious Diseases, 2000
- A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For HumansThe Journal of Infectious Diseases, 1994
- Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cellsArchiv für die gesamte Virusforschung, 1994
- Dengue and dengue hemorrhagic feverThe Pediatric Infectious Disease Journal, 1992
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988